• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞特异性SLC27A4缺失通过抑制磷脂酰胆碱介导的PXR激活改善小鼠非酒精性脂肪性肝病。

Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation.

作者信息

Shen Chuangpeng, Pan Zhisen, Xie Wenmin, Zhao Jian, Miao Deyu, Zhao Ling, Liu Min, Zhong Yanhua, Zhong Chong, Gonzalez Frank J, Wang Wei, Gao Yong, Liu Changhui

机构信息

State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405,China; ShenShan Hospital, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Shanwei 516600,China.

State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

出版信息

Metabolism. 2025 Jan;162:156054. doi: 10.1016/j.metabol.2024.156054. Epub 2024 Nov 1.

DOI:10.1016/j.metabol.2024.156054
PMID:39489412
Abstract

BACKGROUND

The protein Solute carrier family 27 member 4 (SLC27A4) is crucial for fatty acid synthesis and β-oxidation, but its role in hepatic steatosis and nonalcoholic fatty liver disease (NAFLD) progression is not fully understood.

METHODS

Mice with AAV-mediated overexpression of Slc27a4 in liver and hepatocytes-specific deletion of Slc27a4 were fed a standard chow diet, a high-fat diet (HFD), or a methionine and choline-deficient diet (MCD). Serum and liver tissues were collected and analyzed by biochemical assay, histology, lipidomic analysis, RNA-seq analysis, qPCR, western blot and immunofluorescence.

RESULTS

This study found elevated expression of SLC27A4 in individuals with NAFLD and OAPA-treated MPHs cells, leading to increased lipid accumulation and diet-induced liver steatosis, inflammation, and fibrosis. Conversely, hepatocyte-specific deletion of Slc27a4 improved the development of both NAFLD and NASH. SLC27A4 overexpression resulted in increased hepatic pregnane X receptor (PXR) expression and accumulation of phosphatidylcholine (PC), which activates PXR signaling and inducing SLC27A4 expression. PXR overexpression hinders the protective impact of Slc27a4 deletion on lipid accumulation and inflammation, whereas its deficiency in mice reduces the effect of Slc27a4 overexpression on NAFLD development.

CONCLUSION

These results indicate that SLC27A4 plays a critical role of lipid accumulation and inflammation, and is implicated in the development of NAFLD progression, rendering it potentially actionable target for NAFLD treatment.

摘要

背景

溶质载体家族27成员4(SLC27A4)蛋白对脂肪酸合成和β-氧化至关重要,但其在肝脂肪变性和非酒精性脂肪性肝病(NAFLD)进展中的作用尚未完全明确。

方法

用腺相关病毒介导肝脏中Slc27a4过表达以及肝细胞特异性缺失Slc27a4的小鼠,分别给予标准饲料、高脂饮食(HFD)或蛋氨酸和胆碱缺乏饮食(MCD)。收集血清和肝脏组织,通过生化检测、组织学、脂质组学分析、RNA测序分析、定量聚合酶链反应(qPCR)、蛋白质免疫印迹法和免疫荧光法进行分析。

结果

本研究发现,NAFLD患者以及经奥氮平处理的人多能肝细胞(MPHs)中SLC27A4表达升高,导致脂质蓄积增加以及饮食诱导的肝脂肪变性、炎症和纤维化。相反,肝细胞特异性缺失Slc27a4可改善NAFLD和非酒精性脂肪性肝炎(NASH)的发展。SLC27A4过表达导致肝脏孕烷X受体(PXR)表达增加和磷脂酰胆碱(PC)蓄积,激活PXR信号并诱导SLC27A4表达。PXR过表达阻碍Slc27a4缺失对脂质蓄积和炎症的保护作用,而其在小鼠中的缺乏则降低了Slc27a4过表达对NAFLD发展的影响。

结论

这些结果表明,SLC27A4在脂质蓄积和炎症中起关键作用,并与NAFLD进展的发生有关,使其成为NAFLD治疗潜在的可作用靶点。

相似文献

1
Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation.肝细胞特异性SLC27A4缺失通过抑制磷脂酰胆碱介导的PXR激活改善小鼠非酒精性脂肪性肝病。
Metabolism. 2025 Jan;162:156054. doi: 10.1016/j.metabol.2024.156054. Epub 2024 Nov 1.
2
Cassia mimosoides L. decoction improves non-alcoholic fatty liver disease by modulating the pregnane X receptor.含羞草决明汤通过调节孕烷X受体改善非酒精性脂肪性肝病。
J Ethnopharmacol. 2025 Jan 31;340:119199. doi: 10.1016/j.jep.2024.119199. Epub 2024 Dec 3.
3
Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.孕烷X受体加剧非酒精性脂肪性肝病,伴有易引发肥胖和炎症的肠道微生物群特征。
Biochem Pharmacol. 2021 Nov;193:114698. doi: 10.1016/j.bcp.2021.114698. Epub 2021 Jul 23.
4
Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.维生素 D 受体靶向肝细胞核因子 4α 并介导维生素 D 在非酒精性脂肪性肝病中的保护作用。
J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12.
5
The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.全氟辛烷酸对高脂饮食诱导的小鼠非酒精性脂肪性肝病的影响。
Toxicology. 2019 Mar 15;416:1-14. doi: 10.1016/j.tox.2019.01.017. Epub 2019 Jan 31.
6
CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation.饮食诱导的非酒精性脂肪性肝病期间 CYP3A 的抑制与 PXR 调节无关。
Chem Biol Interact. 2019 Aug 1;308:185-193. doi: 10.1016/j.cbi.2019.05.038. Epub 2019 May 24.
7
Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.肝小异二聚体伴侣的破坏可诱导实验性非酒精性脂肪性肝炎中脂肪变性和炎症的分离。
J Biol Chem. 2020 Jan 24;295(4):994-1008. doi: 10.1074/jbc.RA119.010233. Epub 2019 Dec 12.
8
Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.髓系细胞特异性阻断 Notch 信号通路可改善小鼠非酒精性脂肪性肝病。
Int J Biol Sci. 2023 Mar 27;19(6):1941-1954. doi: 10.7150/ijbs.80122. eCollection 2023.
9
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.樟芝及其复合成分去氢表雄酮酸通过上调 ALDH2 活性来减轻非酒精性脂肪肝疾病。
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.
10
Testosterone deficiency aggravates diet-induced non-alcoholic fatty liver disease by inducing hepatocyte ferroptosis via targeting BMAL1 in mice.睾酮缺乏通过靶向小鼠中的BMAL1诱导肝细胞铁死亡,加重饮食诱导的非酒精性脂肪性肝病。
Int Immunopharmacol. 2025 Jan 10;144:113641. doi: 10.1016/j.intimp.2024.113641. Epub 2024 Nov 22.

引用本文的文献

1
Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer.孕烷X受体在代谢性疾病和癌症中的作用机制及治疗进展
Int J Mol Sci. 2025 Aug 20;26(16):8029. doi: 10.3390/ijms26168029.
2
Orchestration of Gut-Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation.非酒精性脂肪性肝病中肠道-肝脏相关转录因子的调控:从跨器官相互作用到治疗创新
Biomedicines. 2025 Jun 10;13(6):1422. doi: 10.3390/biomedicines13061422.
3
Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation.
半剂量瑞美鲁肽与二甲双胍联合治疗通过改善胆固醇代谢和炎症减轻代谢功能障碍相关脂肪性肝炎
Biomedicines. 2025 May 27;13(6):1315. doi: 10.3390/biomedicines13061315.